Published: 01-08-2016
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 44 | PDF Downloads 28Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 36 | PDF Downloads 42Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 38 | PDF Downloads 62Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 60 | PDF Downloads 133Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 55 | PDF Downloads 56Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 61 | PDF Downloads 21Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 41 | PDF Downloads 37Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 98 | PDF Downloads 58Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 64 | PDF Downloads 43Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 59 | PDF Downloads 29Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 40 | PDF Downloads 48Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 31 | PDF Downloads 30Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 54 | PDF Downloads 23Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 60 | PDF Downloads 25Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 56 | PDF Downloads 51Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 61 | PDF Downloads 32Page 191-194